I agree that this site is using cookies. You can find further informations here.
X
Wilgenhof, Sofie
63  results:
Search for persons X
?
1

Real-world health-related quality of life outcomes for pati..:

Egeler, Mees ; Lai-Kwon, Julia ; Tissier, Renaud...
European Journal of Cancer.  200 (2024)  - p. 113601 , 2024
Link: https://doi.org/10.1016/..
 
?
2

IMPemBra: a phase 2 study comparing pembrolizumab with inte..:

Rozeman, Elisa A ; Versluis, Judith M ; Sikorska, Karolina...
Journal for ImmunoTherapy of Cancer.  11 (2023)  7 - p. e006821 , 2023
Link: https://doi.org/10.1136/..
 
?
3

Indications and Outcomes for Deferred Cytoreductive Nephrec..:

Fransen van de Putte, Elisabeth E. ; van den Brink, Luna ; Mansour, Mohamed A....
European Urology Open Science.  55 (2023)  - p. 15-22 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Real-world data on tolerability and clinical response of ce..:

Rohaan, Maartje W. ; Duizer, Marleen L. ; Devriese, Lot A....
EJC Skin Cancer.  1 (2023)  - p. 100007 , 2023
Link: https://doi.org/10.1016/..
 
?
5

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well..:

Fraterman, Itske ; Wollersheim, Barbara M ; Tibollo, Valentina...
JMIR Research Protocols.  12 (2023)  - p. e49252 , 2023
Link: https://doi.org/10.2196/..
 
?
6

Common toxicities associated with immune checkpoint inhibit..:

Egeler, Mees D. ; van Leeuwen, Marieke ; Fraterman, Itske...
Critical Reviews in Oncology/Hematology.  183 (2023)  - p. 103919 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Neoadjuvant nivolumab + T-VEC combination therapy for resec..:

Rohaan, Maartje W. ; Stahlie, Emma H. A. ; Franke, Viola...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
8

Diagnostic performance of early increase in S100B or LDH as..:

Rozeman, Elisa A. ; Versluis, Judith M. ; Moritz, Ruben...
Clinica Chimica Acta.  533 (2022)  - p. 71-78 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Exploring supportive care and information needs through a p..:

Fraterman, Itske ; Glaser, Savannah L. C. ; Wilgenhof, Sofie...
Supportive Care in Cancer.  30 (2022)  9 - p. 7249-7260 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Primary Renal Tumour Response in Patients Treated with Nivo..:

Meerveld-Eggink, Aafke ; Graafland, Niels ; Wilgenhof, Sofie...
European Urology Open Science.  35 (2022)  - p. 54-58 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Sex-Based Differences in Treatment with Immune Checkpoint I..:

van der Kooij, Monique ; Dekkers, Olaf ; Aarts, Maureen...
Cancers.  13 (2021)  18 - p. 4639 , 2021
Link: https://doi.org/10.3390/..
 
?
12

Nivolumab-Induced Exocrine Pancreatic Insufficiency:

Sweep, Boudewijn ; Wilgenhof, Sofie ; Anten, Sander
Case Reports in Oncology.  14 (2021)  3 - p. 1627-1631 , 2021
Link: https://doi.org/10.1159/..
 
?
13

Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibitio..:

Blankenstein, Stéphanie A. ; Rohaan, Maartje W. ; Klop, Willem Martin C....
Annals of Surgery.  274 (2021)  2 - p. 383-389 , 2021
Link: https://doi.org/10.1097/..
 
?
14

TriMix and tumor antigen mRNA electroporated dendritic cell..:

De Keersmaecker, Brenda ; Claerhout, Sofie ; Carrasco, Javier...
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000329 , 2020
Link: https://doi.org/10.1136/..
 
?
15

Switch to checkpoint inhibition after targeted therapy at t..:

Reijers, Irene L. M. ; Rozeman, Elisa A. ; Wilgenhof, Sofie...
Pigment Cell & Melanoma Research.  33 (2019)  3 - p. 498-506 , 2019
Link: https://doi.org/10.1111/..
 
1-15